Ipswich Hospital is a large district general hospital in Heath Road, Ipswich, Suffolk, England. It is now managed by East Suffolk and North Essex NHS Foundation Trust which was formed on 1 July 2018 by the merging of Ipswich Hospital NHS Trust with Colchester Hospital University NHS Foundation Trust.

There are 552 (approx) beds in Ipswich Hospital.

During the past decade, Ipswich Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 9 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 4 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ipswich Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 13 trials, followed by "Medical Research Council" with 7 trials sponsored, "University College, London" with 7 trials sponsored, "East Suffolk and North Essex NHS Foundation Trust" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 66 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ipswich Hospital" #1 collaborator was "Cancer Research UK" with 9 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 66 different institutions and companies that were collaborators in the rest 72 trials.

According to Clinical.Site data, the most researched conditions in "Ipswich Hospital" are "Breast Cancer" (13 trials), "Prostate Cancer" (11 trials), "Ovarian Cancer" (9 trials), "Fallopian Tube Cancer" (7 trials) and "Primary Peritoneal Cavity Cancer" (6 trials). Many other conditions were trialed in "Ipswich Hospital" in a lesser frequency.

Most popular intervention types in "Ipswich Hospital" are "Drug" (67 trials), "Procedure" (23 trials), "Radiation" (21 trials), "Other" (15 trials) and "Biological" (10 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (11 trials), "Placebo" (9 trials), "adjuvant therapy" (8 trials), "cyclophosphamide" (6 trials) and "capecitabine" (5 trials). Other intervention names were less common.

The vast majority of trials in "Ipswich Hospital" are 73 trials for "All" genders, 19 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Ipswich Hospital". undefined are not yet recruiting, 12 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Ipswich Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ipswich Hospital, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 19 trials that are defined as “Not Applicable".

Ipswich Hospital has several departments that took part in Clinical trials: "Ipswich Hospital; Oncology Pharmacy" - 5 trials